LeslieAnneFecherMD

PubMed

• The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.
  Castellano, C., Sun, T., Ravindranathan, D., Hwang, C., Balanchivadze, N., Singh, S., Griffiths, E., Puzanov, I., Ruiz-Garcia, E., Vilar-Compte, D., Cárdenas-Delgado, ...> ;Cancer. 2024 Feb 20
• A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in Melanoma.
  Yen-Chou Chen, Muhammad Jaffer, Lylybell Zhou, Javid Moslehi, Peter A Forsyth, Leslie A Fecher> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 May 1
• 15 citations
  Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238.
  James Larkin, Michele Del Vecchio, Mario Mandalá, Helen Gogas, Ana M Arance Fernandez, Stéphane Dalle, Charles Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna ...> ;Clinical Cancer Research. 2023 Sep 1
• 2 citations
  Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
  Bashir, B., Bashir, B., Johnson, D., Atkins, M., Hennessy, C., Wise-Draper, T., Heilman, H., Awosika, J., Bakouny, Z., Labaki, C., Saliby, R., Hwang, C., Singh, S., Ba...> ;BMC Cancer. 2023 Mar 23
• 116 citations
  Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
  Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright Jr, Kathleen J Yost, John R Hyngstrom, Siwen Hu-Lieskovan, Christopher D Lao, Leslie A Fecher, Thach-Giao Truon...> ;The New England Journal of Medicine. 2023 Mar 2
• 20 citations
  Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
  Vikas, P., Bakouny, Z., Labaki, C., Grover, P., Awosika, J., Gulati, S., Hsu, C., Alimohamed, S., Bashir, B., Berg, S., Bilen, M., Bowles, D., Castellano, C., Desai, A...> ;JAMA Oncology. 2023 Jan 1
• 21 citations
  Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.
  Alexi Vasbinder, YeeAnn Chen, Adrien Procureur, Allison Gradone, Tariq U Azam, Daniel Perry, Husam Shadid, Elizabeth Anderson, Tonimarie Catalan, Pennelope Blakely, Na...> ;JACC. Cardiooncology. 2022 Dec 1
• 3 citations
  Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma.
  Jessica J Waninger, Leslie A Fecher, Christopher Lao, Sarah Yentz, Michael D Green, Hakan Demirci> ;Cancers. 2022 Nov 24
• 3 citations
  Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.
  Wagner, M., Hennessy, C., Beeghly, A., French, B., Shah, D., Croessmann, S., Vilar-Compte, D., Ruiz-Garcia, E., Ingham, M., Schwartz, G., Painter, C., Chugh, R., Feche...> ;Cancers. 2022 Sep 5
• 13 citations
  Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria.
  James Larkin, Jeffrey Weber, Michele Del Vecchio, Helen Gogas, Ana M Arance, Stephane Dalle, C Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion-Sileni,...> ;European Journal of Cancer. 2022 Sep 1
• 4 citations
  Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes.
  Alexander M Balinski, Alexi L Vasbinder, Tonimarie C Catalan, Nathan P Parry, Rafey A Rehman, Pennelope Blakely, Raymond Y Yeow, Monika J Leja, Christopher D Lao, Lesl...> ;Cancer Medicine. 2023 Feb 1
• 10 citations
  American Association of Clinical Endocrinology Disease State Clinical Review: Evaluation and Management of Immune Checkpoint Inhibitor-Mediated Endocrinopathies: A Pra...
  Kevin C J Yuen, Susan L Samson, Irina Bancos, Aidar R Gosmanov, Sina Jasim, Leslie A Fecher, Jeffrey S Weber> ;Endocrine Practice. 2022 Jul 1
• 11 citations
  Successful use of secukinumab in two melanoma patients with immune checkpoint inhibitor-induced inflammatory arthropathy.
  Vincent T Ma, Christopher D Lao, Leslie A Fecher, Elena Schiopu> ;Immunotherapy. 2022 Jun 1
• 2 citations
  The Role of Tissue Biopsy in the Management of Immune Checkpoint Inhibitor Toxicity.
  Leslie A Fecher, Shrinivas Bishu, Robert J Fontana, Salim S Hayek, Bryan J Schneider> ;Journal of the National Comprehensive Cancer Network. 2022 Apr 1
• 32 citations
  Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.
  Vikas, P., Fu, J., Reid, S., French, B., Hennessy, C., Hwang, C., Gatson, N., Duma, N., Mishra, S., Nguyen, R., Hawley, J., Singh, S., Chism, D., Venepalli, N., Warner...> ;JAMA Network Open. 2022 Mar 1
• 5 citations
  Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.
  Jessica E Hawley, Tianyi Sun, David D Chism, Narjust Duma, Julie C Fu, Na Tosha N Gatson, Sanjay Mishra, Ryan H Nguyen, Sonya A Reid, Oscar K Serrano, Sunny R K Singh,...> ;JAMA Network Open. 2022 Jan 4
• 2 citations
  Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma.
  Morgan Homan, Govind Warrier, Christopher D Lao, Sarah Yentz, Shawna Kraft, Leslie A Fecher> ;Frontiers in Oncology. 2022 Jan 1
• 2 citations
  Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.
  Vincent T Ma, Alahendra A Chamila Perera, Yilun Sun, Merna Sitto, Jessica J Waninger, Govind Warrier, Michael D Green, Leslie A Fecher, Christopher D Lao> ;Frontiers in Immunology. 2022 Jan 1
• 90 citations
  Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.
  Bianca Santomasso, Loretta J. Nastoupil, Sherry Adkins, Christina Lacchetti, Bryan J. Schneider, Milan J. Anadkat, Michael B. Atkins, Kelly J. Brassil, Jeffrey M. Cate...> ;Journal of Clinical Oncology. 2021 Nov 1
• 458 citations
  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
  Bryan J. Schneider, Jarushka Naidoo, Bianca Santomasso, Christina Lacchetti, Sherry Adkins, Milan J. Anadkat, Michael B. Atkins, Kelly J. Brassil, Jeffrey M. Caterino,...> ;Journal of Clinical Oncology. 2021 Nov 1
• 8 citations
  Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
  Mario Mandalà, James E. Larkin, Paolo A. Ascierto, Michele Del Vecchio, Helen Gogas, C. Lance Cowey, Ana Arance, Stéphane Dalle, Michael Schenker, Jean-Jacques Grob, V...> ;Journal for Immunotherapy of Cancer. 2021 Aug 1
• 38 citations
  Palliative care, version 2.2021 featured updates to the nccn guidelines
  Maria Dans, Jean S. Kutner, Rajiv Agarwal, Justin N. Baker, Jessica Bauman, Anna C. Beck, Toby C. Campbell, Elise C. Carey, Amy A. Case, Shalini Dalal, Danielle J. Dob...> ;Journal of the National Comprehensive Cancer Network. 2021 Jul 28
• 208 citations
  Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
  Petros Grivas, Ali Raza Khaki, Trisha Wise-Draper, Benjamin French, C. Hennessy, Chih-Yuan Hsu, Yu Shyr, X. Li, Toni K. Choueiri, Corrie A. Painter, Solange Peters, Br...> ;Annals of Oncology. 2021 Jun 1
• 4 citations
  Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.
  Patricia LoRusso, Aleksandar Sekulic, Jeffrey A. Sosman, Winnie S. Liang, John D. Carpten, David Craig, David B. Solit, Alan H. Bryce, Jeff Kiefer, Jessica Aldrich, Sa...> ;Plos One. 2021 Apr 7
• 14 citations
  Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
  Jessica Waninger, Vincent T. Ma, Jeremy Skvarce, Zoey Chopra, Alangoya Tezel, Alex K. Bryant, Charles S. Mayo, Yilun Sun, Kamya Sankar, Nithya Ramnath, Christopher D. ...> ;JAMA Network Open. 2021 Mar 1
• Join now to see all

Lectures

• PD-L1 Testing: Is It Needed to Decide an Immunotherapy Treatment Plan? 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019